Health Canada approves 1st COVID-19 vaccine for youngest kids - CBC News | Canada News Media
Connect with us

News

Health Canada approves 1st COVID-19 vaccine for youngest kids – CBC News

Published

 on


Nearly two million of Canada’s youngest children will soon be eligible for immunization against COVID-19 now that the federal drug regulator has approved Moderna’s COVID-19 vaccine for infants and preschoolers.

Health Canada now says the Moderna vaccine can be given to young children between the ages of six months and five years in doses one-quarter the size of those approved for adults.

Moderna’s product is the first COVID-19 vaccine approved for children under five in Canada.

“After a thorough and independent scientific review of the evidence, the department has determined that the vaccine is safe and effective at preventing COVID-19 in children between six months and five years of age,” the Public Health Agency of Canada announced on Twitter Thursday.

The agency said it will continue to keep a close eye on the safety of the vaccine and has required Moderna to provide updated data on the safety and effectiveness of the vaccine.

In the decision posted on the Health Canada website, the agency said Phase 3 trial results for the drug show the immune response in children aged six months to five years was comparable to Moderna’s vaccine for 18- to 25-year-olds.

WATCH | Health Canada say it will continue to monitor the vaccine’s safety and effectiveness following approval

Health Canada approves Moderna vaccine for children 6 months to 5 years

6 hours ago

Duration 1:51

Health Canada adviser Dr. Supriya Sharma says the agency will continue to receive data from Moderna regarding its safety and effectiveness following its approval for use in younger children.

Trials studying the vaccine’s effectiveness in young children were conducted this past winter when the Omicron variant became dominant.

Preliminary data showed the Moderna vaccine prevented symptomatic COVID-19 at a rate of 50.6 per cent in children between 6 and 23 months old, and at a rate of 36.8 per cent in children 2 to 5 years old.

About 1.7 million kids now eligible for vaccination

The approval expands COVID-19 vaccine eligibility to approximately 1.7 million children in Canada. The provinces will decide where and when the vaccine will be given to kids.

Dr. Howard Njoo, Canada’s deputy chief public health officer, said that even children already infected with COVID-19 would benefit from the vaccine’s added protection.

“COVID-19 vaccination in younger children will increase their protection against severe illness,” Njoo told a news conference. “Even if a child has been previously infected with COVID-19, vaccination is still important.”

Vaccines administered to children between six months and five years old will be about about a quarter of the size of adult doses. (Garrett Barry/CBC)

Health officials said that children who have tested positive for COVID-19 or display symptoms should wait eight weeks before starting the series of vaccinations.

The authorized interval for the two vaccine doses is four weeks, although NACI recommends a period of eight weeks between shots. It says the longer period can result in a more robust and durable immune response.

No safety concerns detected

Health Canada said there were no safety concerns identified in the study. The most common reactions were similar to the ones kids experience with other pediatric vaccines, such as pain at the injection site, sleepiness and loss of appetite.

Less common reactions included mild to moderate fever, swelling at the injection site, nausea, tender lymph nodes under the arm, headaches and muscle aches.

The advisory body noted that adverse side effects occurring at a rate of less than 6 per 100,000 likely would not have been detected during the trial.

Health Canada said there are still some uncertainties about the vaccine because it’s new and researchers don’t have long-term data yet. For example, there’s little information about the risk of very rare reactions like myocarditis — a swelling of heart tissue — although no such cases came up during the trials.

Dr. Tehseen Ladha, an Edmonton-based pediatrician, said the evidence in favour of vaccination remains overwhelming.

WATCH | Pediatrician offers vaccination advice to parents of young children

Newly approved COVID-19 vaccine for children ‘a beacon of light,’ pediatrician says

3 hours ago

Duration 6:17

Pediatrician Dr. Tehseen Ladha says Moderna’s newly approved COVID-19 vaccine for children under five is safer than potentially exposing children to the virus.

“If we’re going to weigh the risks and benefits, we’re looking at whether to give a vaccine that’s been rigorously studied … versus Covid infection, where we don’t know the long-term effects and we do know for certain that it can cause severe consequences,” Ladha told CBC News Network.

To the parents of young children, Ladha said: “I would certainly recommend going for the vaccine rather than exposing them to infection.”

There is also more to learn about the safety and effectiveness of the vaccine in young children with other health conditions or who are immunocompromised, NACI documents said.

The United States approved the Moderna and Pfizer pediatric COVID-19 vaccines last month and has immunized 267,000 children in that age group as of July 8.

Pfizer’s pediatric COVID-19 vaccine for young children between six months and five years old was submitted to Health Canada last month and is still under review.

Dr. Marc Berthiaume of the Health Canada Bureau of Medical Sciences said Canada is not aware of any ongoing studies examining the use of COVID-19 vaccines for children under six months old. He said infants of that age may benefit from antibodies against the coronavirus passed on through their mothers.

Adblock test (Why?)



Source link

Continue Reading

News

Ceiling high for Vancouver Whitecaps midfielder Ahmed: Canada coach

Published

 on

VANCOUVER – Jesse Marsch issued Canada’s men’s soccer squad a challenge — get physical.

The edict came after the Canadians surprised many at this summer’s Copa America tournament, making it through to the semifinals. As his players departed for their professional clubs, the head coach wanted them thinking about continued growth.

“I challenged them to be more physically present in the matches that they played in,” Marsch said. “I’ve tried to encourage all the players to sprint more, to win more duels, to win more balls, to be more dynamic in matches.”

When Canada reconvened for a pair of friendlies last week, the coach saw some players had already heeded his call, including Vancouver Whitecaps product Ali Ahmed.

The 23-year-old midfielder started in both Canada’s 2-1 victory over the United States on Saturday and Tuesday’s 0-0 draw against Mexico.

“I’m really happy for him,” Marsch said. “I think he’s still young and still has a lot of room and potential to continue to grow.”

Playing under Marsch — who took over as head coach in May — has been a boon for the young athlete, currently in his second full season with Major League Soccer’s Whitecaps.

“Jesse has a very clear way of playing,” Ahmed said. “And I think the way we’ve been training and the way we’ve been growing as a group, it’s been helpful for me.”

The reward of getting minutes for a national team can spur a player’s growth, including Ahmed, said Whitecaps head coach Vanni Sartini.

“Of course that fuels him inside to say ‘Hey, I want to be a better player. I want to get to that stage,'” said Sartini.

Vancouver had six players — including Ahmed — away on international duty during its 0-0 draw against Dallas FC on Saturday. The absences are a good problem to have, Sartini said.

“Because we have players that are close to the national team, we have a lot of players that development is faster, better, bigger than it would have been if they hadn’t been called,” he said.

Born in Toronto, Ahmed came up through the Whitecaps’ academy system and played for Vancouver’s MLS Next Pro side before cementing his spot on the first team in 2023. He put up two goals and two assists across 22 regular-season games, and added another goal and another helper in 19 appearances this year.

Taking the next step will require the five-foot-11, 154-pound Ahmed to push himself physically, Marsch said.

“Tactically, he’s technically gifted,” the coach said. “I’ve told him he’s got to get in the gym more.

“There’s a lot of these little things where too many guys, they still look like kids and we need to help them look like men and play like men. And that’s what the high standards of the game are about.”

Marsch has quickly adjusted to recalibrating standards in his short time with Team Canada. Since taking over the squad in May, the coach said he’s learned the players are smarter and more capable than he originally thought, which forces the coach to constantly recalibrate his standards.

“That’s my job right now, to keep raising the level of the demands,” he said.

The way 40th-ranked Canada is viewed on the international stage is evolving, too.

“I think we’re changing the perception on the way we’re playing now,” he said. “I think beating the U.S. — it would have been nice to beat Mexico as well — the way we did, the way that we performed at Copa, I think teams are starting to look at us differently.

“Right now, I think we’re focused on ourselves. We’re definitely trying to be the best in CONCACAF and we have higher goals as well.”

This report by The Canadian Press was first published Sept. 12, 2024.



Source link

Continue Reading

News

Lawyer says Chinese doping case handled ‘reasonably’ but calls WADA’s lack of action “curious”

Published

 on

An investigator gave the World Anti-Doping Agency a pass on its handling of the inflammatory case involving Chinese swimmers, but not without hammering away at the “curious” nature of WADA’s “silence” after examining Chinese actions that did not follow rules designed to safeguard global sports.

WADA on Thursday released the full decision from Eric Cottier, the Swiss investigator it appointed to analyze its handling of the case involving the 23 Chinese swimmers who remained eligible despite testing positive for performance enhancers in 2021.

In echoing wording from an interim report issued earlier this summer, Cottier said it was “reasonable” that WADA chose not to appeal the Chinese anti-doping agency’s explanation that the positives came from contamination.

“Taking into consideration the particularities of the case, (WADA) appears … to have acted in accordance with the rules it has itself laid out for anti-doping organizations,” Cottier wrote.

But peppered throughout his granular, 56-page analysis of the case was evidence and reminders of how WADA disregarded some of China’s violations of anti-doping protocols. Cottier concluded this happened more for the sake of expediency than to show favoritism toward the Chinese.

“In retrospect at least, the Agency’s silence is curious, in the face of a procedure that does not respect the fundamental rules, and its lack of reaction is surprising,” Cottier wrote of WADA’s lack of fealty to the world anti-doping code.

Travis Tygart, the CEO of the U.S. Anti-Doping Agency and one of WADA’s fiercest critics, latched onto this dynamic, saying Cottier’s information “clearly shows that China did not follow the rules, and that WADA management did nothing about it.”

One of the chief complaints over the handling of this case was that neither WADA nor the Chinese gave any public notice upon learning of the positive tests for the banned heart medication Temozolomide, known as TMZ.

The athletes also were largely kept in the dark and the burden to prove their innocence was taken up by Chinese authorities, not the athletes themselves, which runs counter to what the rulebook demands.

Despite the criticisms, WADA generally welcomed the report.

“Above all, (Cottier) reiterated that WADA showed no bias towards China and that its decision not to appeal the cases was reasonable based on the evidence,” WADA director general Olivier Niggli said. “There are however certainly lessons to be learned by WADA and others from this situation.”

Tygart said “this report validates our concerns and only raises new questions that must be answered.”

Cottier expanded on doubts WADA’s own chief scientist, Olivier Rabin, had expressed over the Chinese contamination theory — snippets of which were introduced in the interim report. Rabin was wary of the idea that “a few micrograms” of TMZ found in the kitchen at the hotel where the swimmers stayed could be enough to cause the group contamination.

“Since he was not in a position to exclude the scenario of contamination with solid evidence, he saw no other solution than to accept it, even if he continued to have doubts about the reality of contamination as described by the Chinese authorities,” Cottier wrote.

Though recommendations for changes had been expected in the report, Cottier made none, instead referring to several comments he’d made earlier in the report.

Key among them were his misgivings that a case this big was largely handled in private — a breach of custom, if not the rules themselves — both while China was investigating and after the file had been forwarded to WADA. Not until the New York Times and German broadcaster ARD reported on the positives were any details revealed.

“At the very least, the extraordinary nature of the case (23 swimmers, including top-class athletes, 28 positive tests out of 60 for a banned substance of therapeutic origin, etc.), could have led to coordinated and concerted reflection within the Agency, culminating in a formal and clearly expressed decision to take no action,” the report said.

WADA’s executive committee established a working group to address two more of Cottier’s criticisms — the first involving what he said was essentially WADA’s sloppy recordkeeping and lack of formal protocol, especially in cases this complex; and the second a need to better flesh out rules for complex cases involving group contamination.

___

AP Summer Olympics:



Source link

Continue Reading

News

Shapovalov, Auger-Aliassime lift Canada over Finland 3-0 in Davis Cup tie

Published

 on

MANCHESTER, United Kingdom – Canada’s top male tennis players have defeated Finland 3-0 in the group stage of the Davis Cup Final.

Denis Shapovalov of Richmond Hill, Ont., beat Eero Vasa 7-6 (2), 6-2 in Tuesday’s first singles match. Montreal’s Felix Auger-Aliassime then dispatched Otto Virtanen 6-2, 6-3 in the second singles match.

With the tie already won thanks to the two singles victories, Shapovalov and Auger-Aliassime teamed up to best Virtanen and Harri Heliovaara 6-2, 7-5 in doubles play.

There was an element of revenge after Canada lost to Finland in last year’s quarterfinals.

“Everybody’s in good spirits, so it’s very good,” Auger-Aliassime said. “Any motivation is good, but I think it’s a different year, a different time, and (last year’s loss) was behind us. This year we have a full team and everybody’s playing better than last year. Everybody’s improved.”

It’s the second consecutive group-stage tie Canada has won after beating Argentina 2-1 on Tuesday. Canada, the lone seeded team in Group D, will face host Great Britain on Sunday.

Four groups of teams are playing in four cities this week to qualify for the eight-team Finals in Malaga, Spain, in November. The top two countries in each four-team group advance.

Since Canada’s undefeated after two opponents in the group stage, it is set to advance to the Davis Cup Finals.

“Couldn’t ask for more today, super proud of the team,” said captain Frank Dancevic. “Great team spirit, amazing bench team spirit, and fans pushing us through the day.”

It is Canada’s fifth consecutive appearance in the Davis Cup Finals, having won its only title in 2022. The Canadians defeated South Korea 3-1 in February’s Davis Cup qualifiers in Montreal to reach the group stage of the finals.

— With files from The Associated Press.

This report by The Canadian Press was first published Sept. 12, 2024.

The Canadian Press. All rights reserved.



Source link

Continue Reading

Trending

Exit mobile version